Key Takeaways
- • Underwriters have repriced two Pacific Equity Partners-backed loan facilities upward by 25–50 basis points, with Modern Star Holdings' AUD565 million facility and Healthe Care Australia's AUD310 million facility reflecting tighter investor demand for leveraged debt.
- • Modern Star's senior tranche pricing has increased to 425 basis points over BBSY, while Healthe Care's facility has risen to 500 basis points over BBSY, signaling investor demand for higher compensation amid perceived risk in current market conditions.
- • Modern Star's senior tranche maturity has been compressed from seven years to five years, indicating reduced investor appetite to lock capital over extended periods in volatile market conditions.
- • Barclays and UBS are underwriting the Modern Star transaction, while Standard Chartered and UBS lead the Healthe Care financing, highlighting continued syndication activity despite tightening conditions.
- • Australia's leveraged loan market remains active despite repricing pressures, with parallel debt financings from Bain Capital (AUD430 million for Perpetual Ltd acquisition) and Journey Beyond (AUD768 million) in process.
Summary
Underwriters have repriced upward two major loan facilities for companies backed by Pacific Equity Partners, reflecting a broader contraction in investor appetite for leveraged debt. According to Bloomberg, banks have increased margins by 25–50 basis points on the Modern Star Holdings Bidco Pty education resources facility (AUD565 million) and the Healthe Care Australia Pty hospital operator facility (AUD310 million), demonstrating how syndicated loan markets are recalibrating amid shifting risk dynamics.
The repricing adjustments have moved Modern Star's senior tranche to 425 basis points over the Bank Bill Swap Yield (BBSY), while Healthe Care's facility has been lifted to 500 basis points over BBSY. Beyond pricing, Modern Star's senior tranche maturity has been shortened from seven years to five years, a structural change that reflects reduced investor willingness to commit capital for longer durations in current market conditions. The compressions underscore investor concerns about extended exposure in volatile geopolitical and macroeconomic environments.
Barclays and UBS are jointly underwriting the Modern Star transaction, while Standard Chartered and UBS co-lead the Healthe Care financing. These repricing actions occur against a backdrop of persistent challenges in global syndicated loan markets, where banks continue working through M&A-related leveraged debt backlogs while navigating geopolitical tensions, elevated energy prices, and inflationary pressures that have heightened perceived risk across portfolio exposures.
Despite tightening conditions, Australia's leveraged loan market demonstrates sustained activity. Bain Capital is concurrently marketing a AUD430 million facility tied to its acquisition of Perpetual Ltd's wealth management arm, while tourism group Journey Beyond is pursuing AUD768 million in debt financing. These concurrent transactions indicate that despite margin expansion and maturity compression for certain borrowers, institutional capital continues to deploy into Australian leveraged credit markets, albeit at prices reflecting elevated risk premiums.
The repricing adjustments have moved Modern Star's senior tranche to 425 basis points over the Bank Bill Swap Yield (BBSY), while Healthe Care's facility has been lifted to 500 basis points over BBSY. Beyond pricing, Modern Star's senior tranche maturity has been shortened from seven years to five years, a structural change that reflects reduced investor willingness to commit capital for longer durations in current market conditions. The compressions underscore investor concerns about extended exposure in volatile geopolitical and macroeconomic environments.
Barclays and UBS are jointly underwriting the Modern Star transaction, while Standard Chartered and UBS co-lead the Healthe Care financing. These repricing actions occur against a backdrop of persistent challenges in global syndicated loan markets, where banks continue working through M&A-related leveraged debt backlogs while navigating geopolitical tensions, elevated energy prices, and inflationary pressures that have heightened perceived risk across portfolio exposures.
Despite tightening conditions, Australia's leveraged loan market demonstrates sustained activity. Bain Capital is concurrently marketing a AUD430 million facility tied to its acquisition of Perpetual Ltd's wealth management arm, while tourism group Journey Beyond is pursuing AUD768 million in debt financing. These concurrent transactions indicate that despite margin expansion and maturity compression for certain borrowers, institutional capital continues to deploy into Australian leveraged credit markets, albeit at prices reflecting elevated risk premiums.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.